Literature DB >> 9819353

Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis.

N Ilan1, S Mahooti, J A Madri.   

Abstract

Angiogenesis, the formation of new blood vessels from pre-existing ones, occurs during development, wound healing and cancer and involves stages that orchestrate a network of cooperative interactions. Peptide growth factors and extracellular matrix (ECM) components are two major groups of angiogenesis mediators. Among the different ECM proteins, collagens have been well-associated with in vivo angiogenesis. Using human umbilical vein endothelial cells (HUVEC) grown in 3-D collagen gels we show that: (1) HUVEC do not survive well in 3-D collagen gels due to rapid induction of apoptosis. (2) VEGF, a potent in vivo angiogenic factor, fails to induce tube formation. (3) PMA was effective in inducing tube formation and survival in HUVEC dispersed in 3-D collagen gels, activating MAP kinase, phosphoinositide 3-OH kinase (PI-3-kinase) and Akt/PKB (protein kinase B) pathways. (4) VEGF was effective in preventing PMA-induced tube-like structure regression after PMA-withdrawal by (5) activating the mitogen activated protein kinase (MAPK), rather than the Akt/PKB, signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819353     DOI: 10.1242/jcs.111.24.3621

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  56 in total

1.  Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices.

Authors:  G E Davis; S M Black; K J Bayless
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-09       Impact factor: 2.416

2.  Rho activity critically and selectively regulates endothelial cell organization during angiogenesis.

Authors:  Mien V Hoang; Mary C Whelan; Donald R Senger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

3.  Effect of Integrin Binding Peptide on Vascularization of Scaffold-Free Microtissue Spheroids.

Authors:  Ziyşan Buse Yaralı; Günnur Onak; Ozan Karaman
Journal:  Tissue Eng Regen Med       Date:  2020-07-25       Impact factor: 4.169

Review 4.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

5.  Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood.

Authors:  T-G Chen; J Z Chen; X-X Wang
Journal:  Cell Prolif       Date:  2006-04       Impact factor: 6.831

Review 6.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

7.  Anthrax lethal toxin induces human endothelial cell apoptosis.

Authors:  James E Kirby
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 8.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

9.  Pericytes modulate endothelial sprouting.

Authors:  William G Chang; Jillian W Andrejecsk; Martin S Kluger; W Mark Saltzman; Jordan S Pober
Journal:  Cardiovasc Res       Date:  2013-09-16       Impact factor: 10.787

10.  Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006).

Authors:  Danielle A Murphy; Sosina Makonnen; Wiem Lassoued; Michael D Feldman; Christopher Carter; William M F Lee
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.